55 related articles for article (PubMed ID: 1960012)
1. Inverse relationship between cortisol excretion rate and plasminogen activator inhibitor-1 (PAI-1) antigen and activity in premenopausal obese women.
De Pergola G; De Mitrio V; Cignarelli M; Garruti G; Giorgino F; Meola M; Giorgino R
Int J Obes; 1991 Sep; 15(9):619-22. PubMed ID: 1960012
[TBL] [Abstract][Full Text] [Related]
2. Influence of free testosterone on antigen levels of plasminogen activator inhibitor-1 in premenopausal women with central obesity.
De Pergola G; De Mitrio V; Perricci A; Cignarelli M; Garruti G; Lomuscio S; Ferri G; Schiraldi O; Giorgino R
Metabolism; 1992 Feb; 41(2):131-4. PubMed ID: 1736034
[TBL] [Abstract][Full Text] [Related]
3. Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescents.
Sudi KM; Gallistl S; Weinhandl G; Muntean W; Borkenstein MH
Metabolism; 2000 Jul; 49(7):890-5. PubMed ID: 10910001
[TBL] [Abstract][Full Text] [Related]
4. [The correlation between the activity of tissue plasminogen activator (TPA), levels of tissue plasminogen activator inhibitor (PAI-1) antigen and serum lipids in healthy subjects].
Kobayashi Y; Fukuo Y; Shibuya T; Terashi A
Nihon Ronen Igakkai Zasshi; 1990 Sep; 27(5):578-83. PubMed ID: 2124638
[TBL] [Abstract][Full Text] [Related]
5. Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients--relationship with plasma insulin.
Juhan-Vague I; Roul C; Alessi MC; Ardissone JP; Heim M; Vague P
Thromb Haemost; 1989 Jun; 61(3):370-3. PubMed ID: 2678583
[TBL] [Abstract][Full Text] [Related]
6. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.
Urano T; Sakakibara K; Rydzewski A; Urano S; Takada Y; Takada A
Thromb Haemost; 1990 Feb; 63(1):82-6. PubMed ID: 2111051
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor (PAI) in obese men and obese women.
Cucuianu M; Lanczek M; Roman S
Rom J Intern Med; 1993; 31(3):183-92. PubMed ID: 8130756
[TBL] [Abstract][Full Text] [Related]
8. Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation.
Mertens I; Ballaux D; Funahashi T; Matsuzawa Y; Van der Planken M; Verrijken A; Ruige JB; Van Gaal LF
Thromb Haemost; 2005 Dec; 94(6):1190-5. PubMed ID: 16411393
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
10. The acute effect of insulin on tissue plasminogen activator and plasminogen activator inhibitor in man.
Landin K; Tengborn L; Chmielewska J; von Schenck H; Smith U
Thromb Haemost; 1991 Feb; 65(2):130-3. PubMed ID: 1905068
[TBL] [Abstract][Full Text] [Related]
11. Is visceral adipose tissue a determinant of von Willebrand factor in overweight and obese premenopausal women?
Mertens I; Van der Planken M; Corthouts B; Van Gaal LF
Metabolism; 2006 May; 55(5):650-5. PubMed ID: 16631442
[TBL] [Abstract][Full Text] [Related]
12. Negative correlation between D-dimer and plasminogen activator inhibitor-1 levels is absent in obese women.
Ceo PT; Petruceli E; Bosco AA; Andrade-Fernandes CM; Russi CV; Carvalho Md; Sandrim VC
Blood Coagul Fibrinolysis; 2012 Jul; 23(5):402-5. PubMed ID: 22527291
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F
Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance induced by hydrocortisone is increased in patients with abdominal obesity.
Darmon P; Dadoun F; Boullu-Ciocca S; Grino M; Alessi MC; Dutour A
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E995-E1002. PubMed ID: 16772320
[TBL] [Abstract][Full Text] [Related]
15. Plasma PAI-1 levels in obese children--effect of weight loss and influence of PAI-1 promoter 4G/5G genotype.
Estellés A; Dalmau J; Falcó C; Berbel O; Castelló R; España F; Aznar J
Thromb Haemost; 2001 Aug; 86(2):647-52. PubMed ID: 11522017
[TBL] [Abstract][Full Text] [Related]
16. Effects of short-term exercise training on plasminogen activator inhibitor (PAI-1).
Bodary PF; Yasuda N; Watson DD; Brown AS; Davis JM; Pate RR
Med Sci Sports Exerc; 2003 Nov; 35(11):1853-8. PubMed ID: 14600550
[TBL] [Abstract][Full Text] [Related]
17. Relationship between serum angiotensin-converting enzyme activity and plasma plasminogen activator inhibitor activity in patients with recent myocardial infarction.
Moriyama Y; Ogawa H; Oshima S; Arai H; Takazoe K; Shimomura H; Hirai N; Suefuji H; Soejima H; Nishiyama K; Misumi K; Yasue H
Coron Artery Dis; 1998; 9(10):691-6. PubMed ID: 9894621
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activators t-PA, u-PA and its inhibitor (PAI) in normal males and females.
Koh SC; Yuen R; Viegas OA; Chua SE; Ng BL; Sen DK; Ratnam SS
Thromb Haemost; 1991 Nov; 66(5):581-5. PubMed ID: 1803623
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome.
Glueck CJ; Sieve L; Zhu B; Wang P
Metabolism; 2006 Mar; 55(3):345-52. PubMed ID: 16483878
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor 1 and insulin levels in various insulin resistance states.
Scelles V; Raccah D; Alessi MC; Vialle JM; Juhan-Vague I; Vague P
Diabete Metab; 1992; 18(1):38-42. PubMed ID: 1563535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
